Anti‑inflammatory effects of Panax notoginseng saponins ameliorate acute lung injury induced by oleic acid and lipopolysaccharide in rats

Chen,Yu‑Qing; Rong,Ling; Qiao,Jian‑Ou

doi:10.3892/mmr.2014.2328

Anti‑inflammatory effects of Panax notoginseng saponins ameliorate acute lung injury induced by oleic acid and lipopolysaccharide in rats

Authors:
- Yu‑Qing Chen
- Ling Rong
- Jian‑Ou Qiao
View Affiliations

Affiliations: Department of Respiratory Medicine, Shanghai First People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200080, P.R. China, Department of Respiratory Medicine, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200011, P.R. China
Published online on: June 16, 2014 https://doi.org/10.3892/mmr.2014.2328
Pages: 1400-1408

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study investigated the effect of Panax notoginseng saponins (PNS) on acute lung injury (ALI) induced by oleic acid (OA) and lipopolysaccharide (LPS). A total of 28 Wistar rats were divided into four groups: sham; sham + PNS; OA‑LPS‑induced ALI and ALI + PNS. Lung tissue histology, lung wet‑to‑dry (W/D) weight ratio, extravascular lung water (EVLW) and epithelial sodium channel α (αENaC) mRNA and protein expression were examined. In addition, levels of inﬂammatory cytokines, including tumor necrosis factor α (TNF‑α), interleukin (IL)‑6 and IL‑10, as well as total leukocyte and neutrophil counts, were analyzed in rat bronchoalveolar lavage fluid (BALF) and serum. ALI + PNS rats were observed to exhibit significantly lower pulmonary parenchymal damage and EVLW compared with ALI rats. Furthermore, total leukocyte and neutrophil counts, and levels of inﬂammatory cytokines were significantly decreased following PNS administration in ALI rats. In addition, the decrease in αENaC mRNA and protein expression observed in the lung tissue of ALI rats was partially restored following PNS treatment. PNS treatment was demonstrated to ameliorate OA‑LPS‑induced ALI, potentially through restoration of αENaC mRNA and protein expression and through PNS‑induced anti‑inﬂammatory effects.

View Figures

View References

1	Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 149:818–824. 1994. View Article : Google Scholar
2	Fowler AA, Hamman RF, Good JT, et al: Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med. 98:593–597. 1983. View Article : Google Scholar : PubMed/NCBI
3	Pepe PE, Potkin RT, Reus DH, Hudson LD and Carrico CJ: Clinical predictors of the adult respiratory distress syndrome. Am J Surg. 144:124–130. 1982. View Article : Google Scholar : PubMed/NCBI
4	Rinaldo JE and Christman JW: Mechanisms and mediators of the adult respiratory distress syndrome. Clin Chest Med. 11:621–632. 1990.PubMed/NCBI
5	Ware LB and Matthay MA: Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 163:1376–1383. 2001. View Article : Google Scholar : PubMed/NCBI
6	Matthay MA, Robriquet L and Fang X: Alveolar epithelium: role in lung fluid balance and acute lung injury. Proc Am Thorac Soc. 2:206–213. 2005. View Article : Google Scholar : PubMed/NCBI
7	Canessa CM, Schild L, Buell G, et al: Amiloride-sensitive epithelial Na⁺ channel is made of three homologous subunits. Nature. 367:463–467. 1994. View Article : Google Scholar : PubMed/NCBI
8	Deng W, Li CY, Tong J, Zhang W and Wang DX: Regulation of ENaC-mediated alveolar fluid clearance by insulin via PI3K/Akt pathway in LPS-induced acute lung injury. Respir Res. 13:292012. View Article : Google Scholar : PubMed/NCBI
9	Bellingan GJ: The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS. Thorax. 57:540–546. 2002. View Article : Google Scholar : PubMed/NCBI
10	Goodman RB, Strieter RM, Martin DP, et al: Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 154:602–611. 1996. View Article : Google Scholar : PubMed/NCBI
11	Tomashefski JF Jr: Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med. 21:435–466. 2000. View Article : Google Scholar : PubMed/NCBI
12	Johnson JL, Moore EE, Tamura DY, Zallen G, Biffl WL and Silliman CC: Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release. J Surg Res. 76:91–94. 1998. View Article : Google Scholar : PubMed/NCBI
13	Kiehl MG, Ostermann H, Thomas M, Müller C, Cassens U and Kienast J: Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndrome. Crit Care Med. 26:1194–1199. 1998. View Article : Google Scholar
14	Martin TR: Lung cytokines and ARDS: Roger S. Mitchell Lecture. Chest. 116(Suppl 1): 2S–8S. 1999. View Article : Google Scholar : PubMed/NCBI
15	Meduri GU, Kanangat S, Stefan J, Tolley E and Schaberg D: Cytokines IL-1beta, IL-6, and TNF-alpha enhance in vitro growth of bacteria. Am J Respir Crit Care Med. 160:961–967. 1999. View Article : Google Scholar : PubMed/NCBI
16	Park WY, Goodman RB, Steinberg KP, et al: Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 164:1896–1903. 2001. View Article : Google Scholar : PubMed/NCBI
17	Headley AS, Tolley E and Meduri GU: Infections and the inflammatory response in acute respiratory distress syndrome. Chest. 111:1306–1321. 1997. View Article : Google Scholar : PubMed/NCBI
18	Meduri GU, Kohler G, Headley S, Tolley E, Stentz F and Postlethwaite A: Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest. 108:1303–1314. 1995. View Article : Google Scholar : PubMed/NCBI
19	Li SH and Chu Y: Anti-inflammatory effects of total saponins of Panax notoginseng. Zhongguo Yao Li Xue Bao. 20:551–554. 1999.PubMed/NCBI
20	Ng TB: Pharmacological activity of sanchi ginseng (Panax notoginseng). J Pharm Pharmacol. 58:1007–1019. 2006. View Article : Google Scholar : PubMed/NCBI
21	Sun K, Wang CS, Guo J, et al: Protective effects of ginsenoside Rb1, ginsenoside Rg1, and notoginsenoside R1 on lipopolysaccharide-induced microcirculatory disturbance in rat mesentery. Life Sci. 81:509–518. 2007. View Article : Google Scholar : PubMed/NCBI
22	Rong L, Chen Y, He M and Zhou X: Panax notoginseng saponins attenuate acute lung injury induced by intestinal ischaemia/reperfusion in rats. Respirology. 14:890–898. 2009. View Article : Google Scholar
23	Wang HM, Bodenstein M and Markstaller K: Overview of the pathology of three widely used animal models of acute lung injury. Eur Surg Res. 40:305–316. 2008. View Article : Google Scholar : PubMed/NCBI
24	Vadász I, Morty RE, Kohstall MG, et al: Oleic acid inhibits alveolar fluid reabsorption: a role in acute respiratory distress syndrome? Am J Respir Crit Care Med. 171:469–479. 2005.PubMed/NCBI
25	Adebamiro A, Cheng Y, Johnson JP and Bridges RJ: Endogenous protease activation of ENaC: effect of serine protease inhibition on ENaC single channel properties. J Gen Physiol. 126:339–352. 2005. View Article : Google Scholar : PubMed/NCBI
26	Baines DL, Albert AP, Hazell MJ, Gambling L, Woollhead AM and Dockrell ME: Lipopolysaccharide modifies amiloride-sensitive Na⁺ transport processes across human airway cells: role of mitogen-activated protein kinases ERK 1/2 and 5. Pflugers Arch. 459:451–463. 2010.PubMed/NCBI
27	Shen JF, Qiu HB, Yang Y, et al: Comparison of single-indicator thermodilution versus gravimetric measurement in determination of extra-vascular lung water in dogs with acute respiratory distress syndrome. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 18:327–330. 2006.(In Chinese).
28	Walley KR, Lukacs NW, Standiford TJ, Strieter RM and Kunkel SL: Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun. 64:4733–4738. 1996.PubMed/NCBI
29	Chen C, Zhang F, Xia ZY, Lin H and Mo AS: Protective effects of pretreatment with Radix Paeoniae Rubra on acute lung injury induced by intestinal ischemia/reperfusion in rats. Chin J Traumatol. 11:37–41. 2008.
30	Türüt H, Kurutas EB, Bulbuloglu E, et al: Zinc aspartate alleviates lung injury induced by intestinal ischemia-reperfusion in rats. J Surg Res. 151:62–67. 2009.PubMed/NCBI
31	Ware LB and Matthay MA: The acute respiratory distress syndrome. N Engl J Med. 342:1334–1349. 2000. View Article : Google Scholar : PubMed/NCBI
32	Casey LC, Balk RA and Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 119:771–778. 1993. View Article : Google Scholar : PubMed/NCBI
33	Hack CE, Hart M, van Schijndel RJ, et al: Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun. 60:2835–2842. 1992.PubMed/NCBI
34	Meduri GU, Headley S, Kohler G, et al: Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest. 107:1062–1073. 1995. View Article : Google Scholar
35	Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ and Dupont E: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest. 103:565–575. 1993. View Article : Google Scholar : PubMed/NCBI
36	Sun K, Wang CS, Guo J, et al: Effect of Panax notoginseng saponins on lipopolysaccharide-induced adhesion of leukocytes in rat mesenteric venules. Clin Hemorheol Microcirc. 34:103–108. 2006.
37	Nelson S, Bagby GJ, Bainton BG, Wilson LA, Thompson JJ and Summer WR: Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J Infect Dis. 159:189–194. 1989. View Article : Google Scholar
38	Tutor JD, Mason CM, Dobard E, Beckerman RC, Summer WR and Nelson S: Loss of compartmentalization of alveolar tumor necrosis factor after lung injury. Am J Respir Crit Care Med. 149:1107–1111. 1994. View Article : Google Scholar : PubMed/NCBI
39	Steinberg KP, Mitchell DR, Maunder RJ, Milberg JA, Whitcomb ME and Hudson LD: Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome. Am Rev Respir Dis. 148:556–561. 1993. View Article : Google Scholar : PubMed/NCBI
40	Standiford TJ, Kunkel SL, Phan SH, Rollins BJ and Strieter RM: Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Biol Chem. 266:9912–9918. 1991.
41	Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE and Dayer JM: High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis. 145:1016–1022. 1992. View Article : Google Scholar
42	Moriceau G, Ory B, Gobin B, et al: Therapeutic approach of primary bone tumours by bisphosphonates. Curr Pharm Des. 16:2981–2987. 2010. View Article : Google Scholar : PubMed/NCBI
43	Papanicolaou DA, Wilder RL, Manolagas SC and Chrousos GP: The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 128:127–137. 1998. View Article : Google Scholar : PubMed/NCBI
44	Fiorentino DF, Zlotnik A, Mosmann TR, Howard M and O’Garra A: IL-10 inhibits cytokine production by activated macrophages. J Immunol. 147:3815–3822. 1991.PubMed/NCBI
45	Ramani M, Ollivier V, Khechai F, et al: Interleukin-10 inhibits endotoxin-induced tissue factor mRNA production by human monocytes. FEBS Lett. 334:114–116. 1993. View Article : Google Scholar : PubMed/NCBI
46	Standiford TJ, Strieter RM, Lukacs NW and Kunkel SL: Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol. 155:2222–2229. 1995.
47	van der Poll T, Marchant A, Buurman WA, et al: Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol. 155:5397–5401. 1995.PubMed/NCBI
48	Donnelly SC, Strieter RM, Reid PT, et al: The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med. 125:191–196. 1996. View Article : Google Scholar
49	Lo CJ, Fu M and Cryer HG: Interleukin 10 inhibits alveolar macrophage production of inflammatory mediators involved in adult respiratory distress syndrome. J Surg Res. 79:179–184. 1998. View Article : Google Scholar : PubMed/NCBI
50	Peng XD, Dai LL, Huang CQ, He CM, Yang B and Chen LJ: Relationship between anti-fibrotic effect of Panax notoginseng saponins and serum cytokines in rat hepatic fibrosis. Biochem Biophys Res Commun. 388:31–34. 2009. View Article : Google Scholar : PubMed/NCBI
51	Lee JS, Choi HS, Kang SW, et al: Therapeutic effect of Korean red ginseng on inflammatory cytokines in rats with focal cerebral ischemia/reperfusion injury. Am J Chin Med. 39:83–94. 2011. View Article : Google Scholar : PubMed/NCBI